Acceleron Pharma
American healthcare company / From Wikipedia, the free encyclopedia
Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels.
Quick Facts Company type, Traded as ...
![]() | |
Company type | Subsidiary |
---|---|
Nasdaq: XLRN | |
Industry | Biotechnology |
Founded | 2003; 21 years ago (2003) |
Headquarters | , United States |
Key people | |
Revenue | ![]() |
Number of employees | 225 (Dec 2019) |
Parent | Merck & Co. |
Website | acceleronpharma |
Footnotes / references Key People[3][4] |
Close